Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Masimo ( (MASI) ) has issued an update.
On January 21, 2025, Masimo announced the appointment of Catherine Szyman as its new Chief Executive Officer, effective February 12, 2025, following an extensive search process. Michelle Brennan, who served as interim CEO, will transition to Chairman of the Board. Szyman, with over 35 years of experience, brings a track record of accelerating growth and innovation in patient monitoring, having previously led the Critical Care business at Edwards Lifesciences. Her leadership is expected to drive Masimo’s next phase of innovation, focusing on large opportunities in patient monitoring technologies, while Brennan’s move to Chairman ensures continuity in leadership.
More about Masimo
Masimo is a global medical technology company that specializes in developing and producing advanced monitoring technologies, such as sensors, patient monitors, and automation solutions. The company also operates Masimo Consumer Audio, which includes renowned audio brands like Bowers & Wilkins and Denon. Masimo is committed to improving patient outcomes and reducing healthcare costs.
YTD Price Performance: 2.21%
Average Trading Volume: 553,089
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $9.22B
See more data about MASI stock on TipRanks’ Stock Analysis page.
